Christopher James Sloey

Title: The Innovative Contributions of Christopher James Sloey

Introduction

Christopher James Sloey is a prominent inventor based in Newbury Park, California. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic protein formulations. With a total of 15 patents to his name, Sloey's work has had a substantial impact on medical treatments and drug formulations.

Latest Patents

Sloey's latest patents include an "Aqueous antibody formulation stabilized by antioxidants for parenteral administration." This invention relates to stable aqueous protein formulations that are suitable for parenteral administration and incorporate one or more antioxidants. Another notable patent is for "Low-viscosity, high concentration evolocumab formulations and methods of making the same." This patent provides formulations of PCSK9-binding polypeptides, such as evolocumab, that include N-acetyl arginine, resulting in reduced viscosities compared to formulations lacking this component. These formulations are designed to treat and prevent PCSK9-related diseases, conditions, and disorders.

Career Highlights

Christopher Sloey is currently employed at Amgen Inc., a leading biotechnology company known for its innovative approaches to drug development. His work at Amgen has allowed him to focus on creating advanced therapeutic solutions that address critical health issues.

Collaborations

Sloey has collaborated with notable colleagues, including Tiansheng Li and Jason Ko. These partnerships have contributed to the successful development of his patented formulations and have enhanced the research efforts at Amgen.

Conclusion

Christopher James Sloey's innovative work in the field of biotechnology exemplifies the importance of research and development in creating effective medical treatments. His contributions continue to shape the landscape of therapeutic protein formulations, benefiting patients worldwide.